Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Reprod Biol ; 22(4): 100700, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36240670

RESUMO

Von Willebrand Disease (VWD) is a heritable disorder caused by defects of the Von Willebrand Factor (VWF), leading to deficiencies in coagulation and also angiogenesis. Women affected by VWD frequently show bleeding concerning the reproductive tract and may present with increased rates of miscarriages. We used a porcine model representing VWD type 1 and type 3 as well as the wildtype. Samples were obtained from the reproductive tract of non-pregnant sows and sows pregnant at time of placentation. Relative expression of the genes CALR, CCN2, CXCL8, ECE1, EDN1, F8, IGFBP7, and LGALS3 was analyzed. CCN2 and FVIII proteins were additionally analyzed using immunohistochemistry. In uterus and ovary significant upregulation of CCN2 was seen in non-pregnant pigs affected by VWD. This might be caused by the higher VEGFA-levels in these pigs and could have an influence angiogenesis. During pregnancy, CCN2 expression increased in wildtype pig uteri but hardly changed in those of pregnant pigs affected by VWD, presumably because the expression level in the latter pigs already was significantly increased before pregnancy. F8 expression was significantly reduced in uterus and ovary of VWD-affected pigs. VWF is known to protect FVIII from decomposition and a lack of VWF leads to lower levels of FVIII. Our results suggest that a reduced F8 expression primarily might contribute to those reduced FVIII levels in VWD-affected pigs. Additional significant results involving the pregnant pigs were detected for CALR, EDN1, and LGALS3. These genes are promising candidates for more detailed future studies.


Assuntos
Doença de von Willebrand Tipo 1 , Doenças de von Willebrand , Gravidez , Feminino , Suínos , Animais , Doenças de von Willebrand/genética , Fator de von Willebrand/genética , Fator de von Willebrand/química , Fator de von Willebrand/metabolismo , Indutores da Angiogênese , Galectina 3
2.
Reprod Biol ; 19(4): 412-420, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31806575

RESUMO

Von Willebrand disease (VWD) affects blood coagulation and correlates with angiodysplasia. Data on VWD-affected women point to slightly increased miscarriage rates. We aimed to investigate the impact of VWD on angiogenesis in the uteroplacental unit of pregnant pigs of a model of VWD type 1 (T1). Uteri, placentae, and embryos were harvested at time of placentation (day 29 to 31) from four sows (two wildtype (WT) and two heterozygous for a von Willebrand factor (VWF) mutation diagnosed with T1). T1 sows were bred to a T1 boar creating embryos of three different genotypes: WT, T1 or homozygous for the VWF mutation corresponding with VWD type 3 (T3). Uteroplacental tissues were examined histologically. Embryos were genotyped. Gene expression of angiogenic factors possibly related to VWF was determined by quantitative real-time PCR. Corresponding protein expression was analyzed by immunohistochemistry. Genotyping revealed 35.3% WT, 52.9% T1 and 5.9% T3 embryos (5.9% not classified confidently). No histological alterations were found. Gene expression of VEGF was significantly increased in T1 placentae while expression of ANG1, ANG2, TIE2, and ITGB3 was significantly reduced, confirmed on protein level for different cell types. TIE2/TIE1 ratios were significantly lower in T1 placentae. Distribution of embryo genotypes indicates selection favoring the WT. Significant expression differences of angiogenic factors in placentae suggest influence of VWF on these factors during placentation, although angiodysplasia was not observed. The alterations concerning VEGF/VEGFR-2 signaling, integrin expression and the ANG/TIE system may influence angiogenesis and vascular adaptation during placentation and thus the overall outcome of pregnancy.


Assuntos
Proteínas Angiogênicas/metabolismo , Placenta/metabolismo , Placentação , Útero/metabolismo , Doença de von Willebrand Tipo 1/metabolismo , Animais , Modelos Animais de Doenças , Feminino , Gravidez , Suínos
3.
Comp Med ; 69(5): 401-412, 2019 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-31526432

RESUMO

Von Willebrand disease (VWD), a blood coagulation disorder, is also known to cause angiodysplasia. Hitherto, no animal model has been found with angiodysplasia that can be studied in vivo. In addition, VWD patients tend to have a higher incidence of miscarriages for reasons unknown. Thus, we aimed to examine the influence of von Willebrand factor (VWF) on the female reproductive tract histology and the expression and distribution of angiogenic factors in a porcine model for VWD types 1 and 3. The disease-causing tandem duplication within the VWF gene occurred naturally in these pigs, making them a rare and valuable model. Reproductive organs of 6 animals (2 of each mutant genotype and 2 wildtype (WT) animals) were harvested. Genotype plus phenotype were confirmed. Several angiogenic factors were chosen for possible connections to VWF and analyzed alongside VWF by immunohistochemistry and quantitative gene expression studies. VWD type 3 animals showed angiodysplasia in the uterus and shifting of integrin αVß3 from the apical membrane of uterine epithelium to the cytoplasm accompanied by increased vascular endothelial growth factor (VEGF) expression. Varying staining patterns for angiopoietin (Ang)-2 were observed among the genotypes. As compared with WT, the ovaries of the VWD type 3 animals showed decreased gene expression of ANG2 and increased gene expression of TIE (tyrosine kinase with immunoglobulin and epidermal growth factor homology domains) 2, with some differences in the ANG/TIE-system among the mutant genotypes. In conclusion, severely reduced VWF seems to evoke angiodysplasia in the porcine uterus. Varying distribution and expression of angiogenic factors suggest that this large animal model is promising for investigation of influence of VWF on angiogenesis in larger groups.


Assuntos
Modelos Animais de Doenças , Suínos/genética , Doenças de von Willebrand/genética , Moduladores da Angiogênese/farmacologia , Animais , Genótipo , Humanos , Fenótipo , Receptor de TIE-1 , Receptor TIE-2 , Fator de von Willebrand
4.
G3 (Bethesda) ; 8(2): 577-585, 2018 02 02.
Artigo em Inglês | MEDLINE | ID: mdl-29208651

RESUMO

Von Willebrand Disease (VWD) type 3 is a serious and sometimes fatal hereditary bleeding disorder. In pigs, the disease has been known for decades, and affected animals are used as models for the human disease. Due to the recessive mode of inheritance of VWD type 3, severe bleeding is typically seen in homozygous individuals. We sequenced the complete porcine VWF (Von Willebrand Factor) complementary DNA (cDNA) and detected a tandem duplication of exons 17 and 18, causing a frameshift and a premature termination codon (p.Val814LeufsTer3) in the affected pig. Subsequent next generation sequencing on genomic DNA proved the existence of a 12.3-kb tandem duplication associated with VWD. This duplication putatively originates from porcine Short Interspersed Nuclear Elements (SINEs) located within VWF introns 16 and 18 with high identity. The premature termination truncates the VWF open reading frame by a large part, resulting in an almost entire loss of the mature peptide. It is therefore supposed to account for the severe VWD type 3. Our results further indicate the presence of strong, nonsense-mediated decay in VWF messenger RNA (mRNA) containing the duplication, which was supported by the almost complete absence of the complete VWF protein in immunohistochemistry analysis of the VWD-affected pig. In the past, differentiation of wild-type and heterozygous pigs in this VWD colony had to rely on clinical examinations and additional laboratory methods. The present study provides the basis to distinguish both genotypes by performing a rapid and simple genetic analysis.


Assuntos
Duplicação Gênica , Predisposição Genética para Doença/genética , Doenças dos Suínos/genética , Suínos/genética , Doenças de von Willebrand/genética , Fator de von Willebrand/genética , Animais , Sequência de Bases , Códon sem Sentido/genética , Éxons/genética , Mutação da Fase de Leitura , Genótipo , Sequenciamento de Nucleotídeos em Larga Escala/métodos , Humanos , Fator de von Willebrand/metabolismo
5.
Phys Chem Chem Phys ; 11(25): 5154-9, 2009 Jul 07.
Artigo em Inglês | MEDLINE | ID: mdl-19562148

RESUMO

(1)H, (2)H, (19)F and (15)N NMR spectra of a strongly hydrogen-bonded anionic cluster, CNHF(-), as an ion pair with a tetrabutylammonium cation dissolved in CDF(3)-CDF(2)Cl mixture were recorded in the slow exchange regime at temperatures down to 110 K. The fine structure due to spin-spin coupling of all nuclei involved in the hydrogen bridge was resolved. H/D isotope effects on the chemical shifts were measured. The results were compared with those obtained earlier for a similar anion, FHF(-), and interpreted via ab initio calculations of magnetic shielding as functions of internal vibrational coordinates, namely an anti-symmetric proton stretching and a doubly-degenerate bending. The values of primary and secondary isotope effects on NMR chemical shifts were estimated using a power expansion of the shielding surface as a function of vibrational coordinates. A positive primary isotope effect was explained as a result of the decrease of the hydron stretching amplitude upon deuteration. We show that the proton shielding surface has a minimum close to the equilibrium geometry of the CNHF(-) anion, leading to the positive primary H/D isotope effect in a rather asymmetric hydrogen bond. We conclude that caution should be used when making geometric estimations on the basis of NMR data, since the shapes of the shielding functions of the internal vibrational coordinates can be rather exclusive for each complex.


Assuntos
Cianatos/química , Fluoretos/química , Ânions , Ligação de Hidrogênio , Espectroscopia de Ressonância Magnética
6.
Mol Biochem Parasitol ; 144(2): 198-205, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16181688

RESUMO

Inhibitors of dihydrofolate reductase (DHFR) have been mainstays in the treatment of falciparum malaria. Resistance to one of these antifolates, pyrimethamine, is now common in Plasmodium falciparum populations. Antifolates have not traditionally been recommended for treatment of vivax malaria. However, recent studies have suggested that a third-generation antifolate, WR99210, is remarkably effective even against highly pyrimethamine-resistant parasites from both species. Two methods were used to identify a compound that is effective against quadruple mutant alleles from P. falciparum (N51I/C59R/S108N/I164L) and from Plasmodium vivax (57L/111L/117T/173F). The first was simple yeast system used to screen a panel of WR99210 analogs. The biguanide prodrug, JPC-2056, of the 2-chloro-4-trifluoromethoxy analog of WR99210 was effective against both the P. falciparum and P. vivax enzymes, and has been selected for further development. The second method compared the analogs in silico by docking them in the known structure of the P. falciparum DHFR-thymidylate synthase. The program reproduced well the position of the triazine ring, but the calculated energies of ligand binding were very similar for different compounds and therefore did not reproduce the observed trends in biological activity. The WR99210 family of molecules is flexible due to a long bridge between the triazine ring and the substituted benzene. During docking, multiple conformations were observed for the benzene ring part of the molecules in the DHFR active site, making computer-based predictions of binding energy less informative than for more rigid ligands. This flexibility is a key factor in their effectiveness against the highly mutant forms of DHFR.


Assuntos
Desenho de Fármacos , Antagonistas do Ácido Fólico/farmacologia , Plasmodium falciparum/efeitos dos fármacos , Plasmodium vivax/efeitos dos fármacos , Triazinas/farmacologia , Alelos , Animais , Antagonistas do Ácido Fólico/química , Antagonistas do Ácido Fólico/metabolismo , Concentração Inibidora 50 , Modelos Moleculares , Conformação Molecular , Plasmodium falciparum/enzimologia , Plasmodium vivax/enzimologia , Ligação Proteica , Proteínas de Protozoários/química , Proteínas de Protozoários/genética , Proteínas de Protozoários/metabolismo , Tetra-Hidrofolato Desidrogenase/química , Tetra-Hidrofolato Desidrogenase/genética , Tetra-Hidrofolato Desidrogenase/metabolismo , Triazinas/química , Triazinas/metabolismo
7.
J Med Chem ; 47(17): 4188-201, 2004 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-15293991

RESUMO

The increasing awareness of the essential role of RNA in controlling viral replication and in bacterial protein synthesis emphasizes the potential of ribonucleoproteins as targets for developing new antibacterial and antiviral drugs. RNA forms well defined three-dimensional structures with clefts and binding pockets reminiscent of the active sites of proteins. Furthermore, it precedes proteins in the translation pathway; inhibiting the function of a single RNA molecule would result in inhibition of multiple proteins. Thus, small molecules that bind RNA specifically would combine the advantages of antisense and RNAi strategies with the much more favorable medicinal chemistry of small-molecule therapeutics. The discovery of small-molecule inhibitors of RNA with attractive pharmacological potential would be facilitated if we had available effective computational tools of structure-based drug design. Here, we systematically test automated docking tools developed for proteins using existing three-dimensional structures of RNA-small molecule complexes. The results show that the native structures can generally be reproduced to within 2.5 angstroms more than 50-60% of the time. For more than half of the test complexes, the native ligand ranked among the top 10% compounds in a database-scoring test. Through this work, we provide parameters for the validated application of automated docking tools to the discovery of new inhibitors of RNA function.


Assuntos
Bases de Dados Factuais , Ligantes , RNA/química , Software , Algoritmos , Aminoglicosídeos/química , Antibacterianos/química , Sítios de Ligação , Modelos Moleculares , Conformação de Ácido Nucleico , Relação Quantitativa Estrutura-Atividade , RNA Ribossômico/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...